Consistency between value & price is in our access DNA

We are a healthcare consultancy conceiving and rolling out Global and French-setting applied Market Access and Pricing solutions for health technologies. We intervene at all lifecycle stages from earliest R&D stage to post-launch for defining and achieving rewarding market conditions.

image d'introductionimage d'introduction


From earliest R&D stage to mature commercialization phase

image des servicesimage des services

Strategic Access Road Map
Access Conditions and competitive landscape scanning, benchmarking

Target Product Profile definition
Asset profiling (endpoint selection, effectiveness extrapolation, biomarkers, patient subset…)

Value development plans
Clinical and economic value pillar identification, value de-risking Plan (incl. HEOR plan, ATC code..), Payer Evidence Set, Value Dossiers

Price anchoring, Pricing strategies, new Pricing models

Early dialogues
With HTA bodies at EU & French levels

Interviews/Advisory Board
With Payers, proxy Payers & KoL

Early & Accelerated Access programs

Late dialogues
With HTA body at the EU level

HTA applications
At the French & EU levels

HTA body hearing
Preparation & attendance

Policy definition, negotiation support & contracting insights

Post reimbursement commitment

Real Life value

Drug reimbursement status
Renewal, re-evaluation

HTA application
For line extension

Renegotiation, price increase, price cut minimization


Asset, pipeline, portfolio value assessement
Indication trade-off
Value audit of early stage programme
Clinician / Payer Advisory Board for entry into a new therapeutic area


Market Access strategy plan & roll out
Early Access & regular access support
Sales forecasting
Market Access project management


Asset / portfolio assessment for licensing-in, -out & M&A exercices
Commercial Due diligence


Corporate Market Access & pricing matters
Support to Public Affairs
Internal capabilities building /interim management / board membership


Competition law exercises
Market Access litigations
Support in Patenting

About us

Dr. Véronique Foutel, the consultancy founder, is well acquainted with the  scientific and economic evidence requirements of HTA evaluators & payers for both new assets and commercialized drugs and the way to generate this evidence in a timely manner.

Véronique gained this extensive drug market access and pricing experience through various job tenures in the French P&R Authorities, within the Pharma Division of Roche for 16 years, where she led the Global Strategic Pricing function, in the biotech field as Executive Committee Member of a listed late clinical stage biotech and now as strategic advisor to various biotech management teams and a finance boutique.

Speaker about the drug Market Access conditions in France and in Europe for les Echos Formation, Véronique gives master’s degree lectures at Paris Dauphine University.

Former hospital resident of Assistance Publique-Hôpitaux de Paris, Véronique holds a doctorate in Pharmaceutical Sciences from the University Paris V Descartes, and is a graduate of the Executive Health Economics programme of the Stockholm School of Economics and of the Roche Executive Leadership programme of the London Business School.


image des partenairesimage des partenaires

eponyme partners

Independent mid-cap mergers and acquisitions boutique website

Mc Arthur and Associates GmbH

Consultancy supporting drug discovery and early clinical development projects and large scientific alliances website


Development consulting, regulatory affairs, quality management, compliance, pharmacovigilance, epidemiology & risk management worldwide website

Public Health Expertise

High-end life-sciences simulations, data analysis and market-access website


Biometrics & methodological expertise for clinical development activities carried out in pre-, peri- & post-launch website


Medical communication & consultancy website


Medical Communication & consultancy website

Our clients





Lifescience Stakeholders


Our events

events imagesevents images

Contact us

  • Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.

contact images